Clinical Trials Directory

Trials / Completed

CompletedNCT04303754

Diabetes-Specific Formula in Individuals With Type 2 Diabetes

A Randomized Controlled Trial to Determine the Effects of Diabetes-Specific Formula on Glycemic Control in Individuals With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Abbott Nutrition · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will be conducted using a randomized, controlled, crossover design with three treatments. The purpose of the study is to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.

Detailed description

All study participants will be asked to attend a test session where their glycemic, insulinemic and satiety response to a test meal will be measured, followed by a seven-day washout period where they will not receive or consume any study meal during this period. This cycle will be repeated until all participants complete three test sessions.

Conditions

Interventions

TypeNameDescription
OTHERDiabetes-Specific FormulaOther: Diabetes Specific Formula
OTHERBread with SpreadOther: White Bread with Spread
OTHERRice PorridgeOther: Rice Porridge

Timeline

Start date
2020-06-24
Primary completion
2022-10-19
Completion
2022-10-19
First posted
2020-03-11
Last updated
2022-12-07

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT04303754. Inclusion in this directory is not an endorsement.

Diabetes-Specific Formula in Individuals With Type 2 Diabetes (NCT04303754) · Clinical Trials Directory